Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets

Physiological Research

Volumn 62, Issue 1, 2013, Pages 1-13

  Farghali, H ^a   Kutinova Canova N ^a   Lekic N ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Epigenetic drug target; Resveratrol; SIRT1 activators

Indexed keywords

ANTIOXIDANT; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; RESVERATROL; SIRTUIN 1; STILBENE DERIVATIVE;

ALLOSTERISM; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; GENETIC EPIGENESIS; HUMAN; METABOLISM; OXIDATIVE STRESS; PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION;

ALLOSTERIC REGULATION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTIOXIDANTS; ENZYME ACTIVATION; ENZYME ACTIVATORS; EPIGENESIS, GENETIC; HUMANS; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PHOSPHORYLATION; SIRTUIN 1; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84876045065     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. AFTAB N, LIKHITWITAYAWUID K, VIEIRA A. Comparative antioxidant activities and synergism of resveratrol and oxyresveratrol. Nat Prod Res 24: 1726-1733, 2010.
2. AGGARWAL BB, SUNDARAM C, MALANI N, ICHIKAWA H. Curcumin: the Indian solid gold. Adv Exp Med Biol 595: 1-75, 2007.
3. ARA C, KIRIMLIOGLU H, KARABULUT AB, COBAN S, AY S, HARPUTLUOGLU M, KIRIMLIOGLU V, YILMAZ S. Protective effect of resveratrol against oxidative stress in cholestasis. J Surgical Res 127: 112-117, 2005.
4. ATHAR M, BACK JH, KOPELOVICH L, BICKERS DR, KIM AL. Multiple molecular targets of resveratrol: anticarcinogenic mechanisms. Arch Biochem Biophys 486: 95-102, 2009.
5. AUGER C, TEISSEDRE PL, GERAIN P, LEQUEUX N, BORNET A, SERISIER S, BESANCON P, CAPORICCIO B, CRISTOL JP, ROUANET JM. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J Agric Food Chem 53: 2015-2021, 2005.
6. BAUR JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev 131: 261-269, 2010.
7. BERESWILL S, MUÑOZ M, FISCHER A, PLICKERT R, HAAG LM, OTTO B, KÜHL AA, LODDENKEMPER C, GÖBEL UB, HEIMESAAT MM. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5: e15099, 2010.
8. BHARRHAN S, CHOPRA K, ARORA SK, TOOR JS, RISHI P. Down-regulation of NF-kB signaling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model. Innate Immun 18: 70-79, 2012.
9. CARLUCCIO MA, ANCORA MA, MASSARO M, CARLUCCIO M, SCODITTI E, DISTANTE A, STORELLI C, DE CATERINA R. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol 293: H2344-H2354, 2007.
10. CERNÝ D, KUTINOVÁ CANOVÁ N, MARTÍNEK J, HORÍNEK A, KMONÍCKOVÁ E, ZÍDEK Z, FARGHALI H. Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1. Nitric Oxide 20: 1-8, 2009.
11. CERNÝ D, LEKIĆ N, VÁNOVÁ K, MUCHOVÁ L, HOŘÍNEK A, KMONÍČKOVÁ E, ZÍDEK Z, KAMENÍKOVÁ L, FARGHALI H. Hepatoprotective effect of curcumin in lipopolysaccharide/-galactosamine model of liver injury in rats: relationship to HO-1/CO antioxidant system. Fitoterapia 82: 786-791, 2011.
12. CHAUDHARY N, PFLUGER PT. Metabolic benefits from Sirt1 and Sirt1 activators. Curr Opin Clin Nutr Metab Care 12: 431-437, 2009.
13. CHEN D, BRUNO J, EASLON E, LIN SJ, CHENG HL, ALT FW, GUARENTE L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 22: 1753-1757, 2008.
14. CHIRUMBOLO S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflamm Allergy Drug Targets 9: 263-285, 2010.
15. CHOW HH, GARLAND LL, HSU CH, VINING DR, CHEW WM, MILLER JA, PERLOFF M, CROWELL JA, ALBERTS DS. Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila) 3: 1168-1175, 2010.
16. CHRISTEN WG, LIU S, GLYNN RJ, GAZIANO JM, BURING JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol 126: 102-109, 2008.
17. DAI H, KUSTIGIAN L, CARNEY D, CASE A, CONSIDINE T, HUBBARD BP, PERNI RB, RIERA TV, SZCZEPANKIEWICZ B, VLASUK GP, STEIN RL. SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem 285: 32695-32703, 2010.
18. DARVESH AS, AGGARWAL BB, BISHAYEE A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol 13: 218-228, 2012.
19. DAUCHET L, AMOUYEL P, HERCBERG S, DALLONGEVILLE J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 136: 2588-2593, 2006.
20. DHERANI M, MURTHY GV, GUPTA SK, YOUNG IS, MARAINI G, CAMPARINI M, PRICE GM, JOHN N, CHAKRAVARTHY U, FLETCHER AE. Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci 49: 3328-3335, 2008.
21. EDWARDS RL, LYON T, LITWIN SE, RABOVSKY A, SYMONS JD, JALILI T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137: 2405-2411, 2007.
22. EGERT S, BOSY-WESTPHAL A, SEIBERL J, KURBITZ C, SETTLEER U, PLACHTA-DANIELZIK S, WAGNER AE, FRANK J, SCHREZENMEIR J, RIMBACH G, WOLFFRAM S, MULLER MJ. Queretin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a highcardiovascular disease risk phenotype: a double blinded, placebo-controlled cross-over study. Br J Nutr 102: 1065-1074, 2009.
23. FARGHALI H, KAMENÍKOVÁ L, HYNIE S. The concept of application of immobilized and perfused mammalian cells (a bioreactor model) in biomedical research. Physiol Res 43: 117-120, 1994a.
24. FARGHALI H, KAMENÍKOVÁ L, MARTÍNEK J, LINCOVÁ D, HYNIE S. Preparation of functionally active immobilized and perfused mammalian cells: an example of the hepatocyte bioreactor. Physiol Res 43: 121-125, 1994b.
25. FARGHALI H, CERNÝ D, KAMENÍKOVÁ L, MARTÍNEK J, HORÍNEK A, KMONÍCKOVÁ E, ZÍDEK Z. Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-Galactosamine sensitized rats: role of nitric oxide synthase 2 and heme oxygenase-1. Nitric Oxide 21: 216-225, 2009.
26. FEIGE JN, LAGOUGE M, CANTO C, STREHLE A, HOUTEN SM, MILNE JC, LAMBERT PD, MATAKI C, ELLIOTT PJ, AUWERX J. Specific SIRT1 activation mimics low energy levels and protects against dietinduced metabolic disorders by enhancing fat oxidation. Cell Metab 8: 347-358, 2008.
27. FULLERTON MD, STEINBERG GR. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 59: 551-553, 2010.
28. GALLEANO M, PECHANOVA O, FRAGA CG. Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharm Biotechnol 11: 837-848, 2010.
29. GHOSH A, MANDAL AK, SARKAR S, DAS N. Hepatoprotective and neuroprotective activity of liposomal quercetin in combating chronic arsenic induced oxidative damage in liver and brain of rats. Drug Deliv 18: 451-459, 2011.
30. HATCHER H, PLANALP R, CHO J, TORTI FM, TORTI SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652, 2008.
31. HEBBAR V, SHEN G, HU R, KIM BR, CHEN C, KORYTKO PJ, CROWELL JA, LEVINE BS, KONG AN. Toxicogenomics of resveratrol in rat liver. Life Sci 76: 2299-2314, 2005.
32. HOU X, XU S, MAITLAND-TOOLAN KA, SATO K, JIANG B, IDO Y, LAN F, WALSH K, WIERZBICKI M, VERBEUREN TJ, COHEN RA, ZANG M. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283: 20015-20026, 2008.
33. JAESCHKE H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 26 (SUPPL 1): 173-179, 2011.
34. JAESCHKE H, MCGILL MR, RAMACHANDRAN A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44: 88-106
35. JEON BT, JEONG EA, SHIN HJ, LEE Y, LEE DH, KIM HJ, KANG SS, CHO GJ, CHOI WS, ROH GS. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61: 1444-1454, 2012.
36. JO HY, KIM Y, NAM SY, LEE BJ, KIM YB, YUN YW, AHN B. The inhibitory effect of quercitin gallate on iNOS expression induced by lipopolysaccharide in BALB/C mice. J Vet Sci 9: 267-272, 2008.
37. KAZANTSEV AG, OUTEIRO TF. Editorial on special topic: sirtuins in metabolism, aging, and disease. Front Pharmacol 3: 71, 2012.
38. KIM YA, KIM GY, PARK KY, CHOI YH. Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J Med Food 10: 218-224, 2007.
39. KUTINOVA-CANOVA N, GAIER N, FARGHALI H. Perspectives on pharmacological and clinical benefits from SIRT1 (silent information regulator T1) activators in oxidative damage. (in Czech) Cas Lek Cesk 151: 187-189, 2012.
40. LEE JH, SONG MY, SONG EK, KIM EK, MOON WS, HAN MK, PARK JW, KWON KB, PARK BH. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes 58: 344-351, 2009.
41. LEKIĆ N, CERNÝ D, HOŘÍNEK A, PROVAZNÍK Z, MARTÍNEK J, FARGHALI H. Differential oxidative stress responses to D-galactosamine-lipopolysaccharide hepatotoxicity based on real time PCR analysis of selected oxidant/antioxidant and apoptotic gene expressions in rat. Physiol Res 60:549-558, 2011.
42. LIN SJ, FORD E, HAIGIS M, LISZT G, GUARENTE L. Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev 18: 12-16, 2004.
43. MANDA K, BHATIA AL. Role of beta-carotene against acetaminophen-induced hepatotoxicity in mice. Nutr Res 23: 1097-1103, 2003.
44. MILNE JC, LAMBERT PD, SCHENK S, CARNEY DP, SMITH JJ, GAGNE DJ, JIN L, BOSS O, PERNI RB, VU CB, BEMIS JE, XIE R, DISCH JS, NG PY, NUNES JJ, LYNCH AV, YANG H, GALONEK H, ISRAELIAN K, CHOY W, IFFLAND A, LAVU S, MEDVEDIK O, SINCLAIR DA, OLEFSKY JM, JIROUSEK MR, ELLIOTT PJ, WESTPHAL CH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007.
45. MOLLICA MP, LIONETTI L, PUTTI R, CAVALIERE G, GAITA M, BARLETTA A. From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation. Nutr Metab Cardiovasc Dis 21: 222-230, 2011.
46. MONOD J, WYMAN J, CHANGEUX JP. On the nature of allosteric transitions: a plausible model. J Mol Biol 12: 88-118, 1965.
47. NAKATA R, TAKAHASHI S, INOUE H. Recent advances in the study on resveratrol. Biol Pharm Bull 35: 273-279, 2012.
48. NG TP, CHIAM PC, LEE T, CHUA HC, LIM L, KUA EH. Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898-906, 2006.
49. PARI L, MURUGAN P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res 49: 481-486, 2004.
50. PERACCHI A, MOZZARELLI A. Exploring and exploiting allostery: models, evolution, and drug targeting. Biochim Biophys Acta 1814: 922-933, 2011.
51. PERVAIZ S, HOLME AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11: 2851-2897, 2009.
52. PFLUGER PT, HERRANZ D, VELASCO-MIGUEL S, SERRANO M, TSCHÖP MH. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105: 9793-9798, 2008.
53. PICARD F, KURTEV M, CHUNG N, TOPARK-NGARM A, SENAWONG T, MACHADO DE OLIVEIRA R, LEID M, MCBURNEY MW, GUARENTE L. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429: 771-776, 2004.
54. RAZA M, AHMAD M, GADO A, AL-SHABANAH OA. A comparison of hepatoprotective activities of aminoguanidine and N-acetylcysteine in rat against the toxic damage induced by azathioprine. Comp Biochem Physiol C Toxicol Pharmacol 134: 451-456, 2003.
55. RODGERS JT, LERIN C, HAAS W, GYGI SP, SPIEGELMAN BM, PUIGSERVER P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113-118, 2005.
56. ROYCE SG, DANG W, YUAN G, TRAN J, EL OSTA A, KARAGIANNIS TC, TANG ML. Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease. Pathobiol Aging Age Relat Dis 1: 7134, 2011.
57. RUDERMAN NB, XU XJ, NELSON L, CACICEDO JM, SAHA AK, LAN F, IDO Y. AMPK and SIRT1: a longstanding partnership? Am J Physiol Endocrinol Metab 298: E751-E760, 2010.
58. SAUVE AA. Pharmaceutical strategies for activating sirtuins. Curr Pharm Des 15: 45-56, 2009.
59. SIKORA E, SCAPAGNINI G, BARBAGALLO M. Curcumin, inflammation, ageing and age-related diseases. Immun Ageing 7: 1, 2010.
60. SIPPL W, JUNG M (eds). Epigenetic Targets in Drug Discovery. Volume 42. Methods and Principles in Medicinal Chemistry. MANNHOLD R, KUBINYI H, FOLKERS G (eds), WILEY-VCH Verlag, Weinheim, 2009.
61. SMOLIGA JM, BAUR JA, HAUSENBLAS HA. Resveratrol and health-a comprehensive review of human clinical trials. Mol Nutr Food Res 55: 1129-1141, 2011.
62. SMOLIGA JM, RUNDELL KW. Oxidative stress: friend and foe of the elite marathoner. J Appl Physiol 110: 287, 2011.
63. SMOLIGA JM, VANG O, BAUR JA. Challenges of translating basic research into therapeutics: resveratrol as an example. J Gerontol A Biol Sci Med Sci 67: 158-167, 2012.
64. SPIEGELMAN BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514, 1998.
65. SUCHANKOVA G, NELSON LE, GERHART-HINES Z, KELLY M, GAUTHIER MS, SAHA AK, IDO Y, PUIGSERVER P, RUDERMAN NB. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 378: 836-841, 2009.
66. ŠVAJGER U, JERAS M. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int Rev Immunol 31: 202-222, 2012.
67. VILLALBA JM, DE CABO R, ALCAIN FJ. A patent review of sirtuin activators: an update. Expert Opin Ther Pat 22: 355-367, 2012.
68. WEBSTER BR, LU Z, SACK MN, SCOTT I. The role of sirtuins in modulating redox stressors. Free Radic Biol Med 52: 281-290, 2012.
69. WENDEBURG L, DE OLIVEIRA AC, BHATIA HS, CANDELARIO-JALIL E, FIEBICH BL. Resveratrol inhibits prostaglandin formation in IL-1beta-stimulated SK-N-SH neuronal cells. J Neuroinflammation 6: 26, 2009.
70. WENG CJ, CHEN MJ, YEH CT, YEN GC. Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing NRF2 DNA-binding activity. N Biotechnol 28: 767-777, 2011.
71. WONG YT, GRUBER J, JENNER AM, NG MP, RUAN R, TAY FE. Elevation of oxidative-damage biomarkers during aging in F2 hybrid mice: protection by chronic oral intake of resveratrol. Free Radic Biol Med 46: 799-809, 2009.
72. WU SL, PAN CE, YU L, MENG KW. Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model. Transplant Proceed 37: 2354-2359, 2005.
73. XIONG S, SALAZAR G, PATRUSHEV N, ALEXANDER RW. FoxO1 mediates an auto-feedback loop regulating SIRT1 expression. J Biol Chem 286: 5289-5299, 2011.
74. YANG H, LEE MK, KIM YC. Protective activities of stilbene glycosides from Acer mono leaves against H2O2-induced oxidative damage in primary cultured rat hepatocytes. J Agric Food Chem 53: 4182-4186, 2005.
75. YANG SR, WRIGHT J, BAUTER M, SEWERYNIAK K, KODE A, RAHMAN I. Sirtuin regulates cigarette smokeinduced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol 292: L567-L576, 2007.
76. YEUM KJ, RUSSEL RM, ALDINI G. Biomarkers for reassemble the results and re-create the whole by human studies. In: Biomarkers for Antioxidant Defence and Oxidative Damage: Principles and Practical Applications.ALDINI G, YEUM KJ, NIKI E, RUSSEL RM (eds), Blackwell Publishing, Ames, Iowa, 2010, pp 3-19.
77. YEUNG F, HOBERG JE, RAMSEY CS, KELLER MD, JONES DR, FRYE RA, MAYO MW. Modulation of NFkappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004
78. ZHAO L, WU J, YANG J, WEI J, GAO W, GUO C. Dietary quercetin supplementation increases serum antioxidant capacity and alters hepatic gene expression profile in rats. Exp Biol Med 236: 701-706, 2011.